RxDoctor Payments Data

Andrew de Jong, MD

Pediatric Otolaryngology · College Station, TXNPI 1750328092

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Stryker at 28.4% of the total.

$872in general payments, 2019–2025

Across 19 payments — averaging $45.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$248
  • Medtronic$195
  • Neurent Medical Limited$119
  • Cochlear Americas$116
  • Acclarent, Inc$67
  • Advanced Bionics, LLC$50
  • plus $77 from 3 others
$1,419in research payments, 2019–2025

Across 2 payments — averaging $709.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cochlear Americas$1K

What the payments were for

  • Food & beverage$872100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$872 in reported general payments places this provider in the 65th percentile of 76 pediatric otolaryngology providers in Texas.

See all pediatric otolaryngology providers in Texas

Medicare billing

Part B allowed, 2024
$375,796
Medicare patients
1,037
Services billed
6,127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Epinephrine21$4,203
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth25$2,823
Ipratropium Bromide84$2,337
Ofloxacin60$1,885
Montelukast Sodium87$812
Azelastine Hcl32$774
Fluticasone Propionate31$388
Prednisolone Acetate11$361
Methylprednisolone31$204
Acetaminophen-CodeineAcetaminophen With Codeine33$181
Mupirocin20$177
Levothyroxine Sodium18$166
Cefdinir11$157
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$110
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid14$68

Paid to pharmacies, not to this prescriber.

Other pediatric otolaryngology in College Station

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →